Orally administered pimonidazole to label hypoxic tumor cells

Cancer Research

Volumn 62, Issue 23, 2002, Pages 6827-6830

  Bennewith, Kevin L ^a   Raleigh, James A ^b   Durand, Ralph E ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (1,1,1,3,3,3 HEXAFLUORO 2 PROPOXY) 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; PIMONIDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL FRACTIONATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; HUMAN; HUMAN CELL; HYPOXIC CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL;

ADMINISTRATION, ORAL; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; NITROIMIDAZOLES; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0036895572     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hockel, M., and Vaupel, P. Tumor hypoxia: Definitions and current clinical, biologic. and molecular aspects. J. Natl. Cancer Inst., 93: 266-276, 2001.
2. Kallinowski, F., Zander, R., Hoeckel, M., and Vaupel, P. Tumor tissue oxygenation as evaluated by computerized-pO2-histography. Int. J. Radiat. Oncol. Biol. Phys., 19: 953-961, 1990.
3. Griffiths, J. R., and Robinson, S. P. The OxyLite: A fibre-optic oxygen sensor. Br. J. Radiol., 72: 627-630, 1999.
4. Olive, P. L., Johnston, P. J., Banath, J. P., and Durand, R. E. The comet assay: A new method to examine heterogeneity associated with solid tumors. Nat. Med., 4: 103-105, 1998.
5. Koh, W. J., Rasey, J. S., Evans, M. L., Grierson, J. R., Lewellen, T. K., Graham, M. M., Krohn, K. A., and Griffin, T. W. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int. J. Radiat. Oncol. Biol. Phys., 22: 199-212, 1992.
6. Kennedy, A. S., Raleigh, J. A., Perez, G. M., Calkins, D. P., Thrall, D. E., Novotny, D. B., and Varia, M. A. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: First report of combined immunohistochemical assays, Int. J. Radiat. Oncol. Biol. Phys., 37: 897-905, 1997.
7. Evans, S. M., Hahn, S., Pook, D. R., Jenkins, W. T., Chalian, A. A., Zhang, P., Stevens, C., Weber, R., Weinstein, G., Benjamin, I., Mirza, N., Morgan, M., Rubin, S., McKenna, W. G., Lord, E. M., and Koch, C. J. Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res., 60: 2018-2024, 2000.
8. Olive, P. L., Durand, R. E., Raleigh, J. A., Luo, C., and Aquino-Parsons, C. Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia. Br. J. Cancer, 83: 1525-1531, 2000.
9. Arteel, G. E., Thurman, R. G., Yates, J. M., and Raleigh, J. A. Evidence that hypoxia markers detect oxygen gradients in liver: Pimonidazole and retrograde perfusion of rat liver. Br. J. Cancer, 72: 889-895, 1995.
10. Raleigh, J. A., Miller, G. G., Franko, A. J., Koch, C. J., Fuciarelli, A. F., and Kelly, D. A. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. Br. J. Cancer, 56: 395-400, 1987.
11. Ljungkvist, A. S., Bussink, J., Rijken, P. F., Raleigh, J. A., Denekamp, J., and Van Der Kogel, A. J. Changes in tumor hypoxia measured with a double hypoxic marker technique. Int. J. Radiat. Oncol. Biol. Phys., 48: 1529-1538, 2000.
12. Chaplin, D. J., Durand. R. E., and Olive. P. L. Cell selection from a murine tumor using the fluorescent probe Hoechst 33342. Br. J. Cancer, 51: 569-572, 1985.
13. Friedl, F., Kimura, I., Osato, T., and Ito, Y. Studies on a new human cell line (SiHa) derived from carcinoma of uterus. I. Its establishment and morphology. Proc. Soc. Exp. Biol. Med., 135: 543-545, 1970.
14. Durand, R. E. Use of a cell sorter for assays of cell clonogenicity. Cancer Res., 46: 2775-2778, 1986.
15. Durand, R. E., and Raleigh, J. A. Identification of nonproliferating but viable hypoxic tumor cells in vivo. Cancer Res., 58: 3547-3550, 1998.
16. Raleigh, J. A., Chou, S. C., Arteel, G. E., and Horsman, M. R. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat. Res., 151: 580-589, 1999.
17. Durand, R. E., and Aquino-Parsons, C. Clinical relevance of intermittent tumour blood flow. Acta Oncol., 40: 929-936, 2001.
18. Durand, R. E. Intermittent blood flow in solid tumours-an under-appreciated source of 'drug resistance'. Cancer Metastasis Rev., 20: 57-61, 2001.
19. Wouters, B. G., and Brown, J. M. Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. Radiat. Res., 147: 541-550, 1997.
20. Denekamp, J., and Dasu, A. Inducible repair and the two forms of tumour hypoxia-time for a paradigm shift. Acta Oncol., 38: 903-918, 1999.